Vann, Kendra R.
Pal, Dhananjaya
Morales, Guillermo A.
Burgoyne, Adam M.
Durden, Donald L.
Kutateladze, Tatiana G.
Funding for this research was provided by:
National Institutes of Health (CA192656, GM135671)
Article History
Received: 17 April 2020
Accepted: 9 June 2020
First Online: 21 July 2020
Competing interest
: G.A.M. and D.L.D. acknowledge financial interest in SignalRx Pharmaceuticals, Inc.